Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 20 Similar Profiles
Vegetables
Medicine & Life Sciences
Biomarkers
Medicine & Life Sciences
Urine
Medicine & Life Sciences
Brassica
Medicine & Life Sciences
Tobacco
Chemical Compounds
Lung Neoplasms
Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Carcinogens
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2010 2023
A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of CombinationTreatment with MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients with Recurrent / MetastaticHuman Papilloma Virus Associated Head and Neck Squamous
5/16/18 → 5/30/23
Project: Research project
Papillomaviridae
Papilloma
Neck
Head
Viruses
Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alonefollowing Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer(NSCLC)
BIG TEN CANCER RESEARCH CONSORTIUM
1/1/18 → 1/31/21
Project: Research project
Chemoradiotherapy
Non-Small Cell Lung Carcinoma
Immunotherapy
nivolumab
ipilimumab
A Phase II Trial of Chemotherapy plus Pembrolizumab in patients with advanced NSCLC previously treatedwith PD-1 or PD-L1 Inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029
BIG TEN CANCER RESEARCH CONSORTIUM
12/1/17 → 11/30/22
Project: Research project
Drug Therapy
Research
Neoplasms
pembrolizumab
Determination of Protein Requirements Using a Stable Iso
Earthman, C. P., Fujioka, N., Patel, M. R. & Vock, D. M.
1/1/16 → 8/31/20
Project: Research project
Point-of-Care Systems
Head and Neck Neoplasms
Isotopes
Equipment and Supplies
Proteins
Non-Small Cell Lung Carcinoma
Mutation
Neoplasms
Therapeutics
gefitinib
Research Output 2010 2019
Detection and quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) from smoker albumin and its potential as a surrogate biomarker of tobacco-specific nitrosamines exposure and bioactivation
Wang, Y., Narayanapillai, S. C., Hu, Q., Fujioka, N. & Xing, C., Sep 1 2019, In : Toxicology Letters. 311, p. 11-16 6 p.Research output: Contribution to journal › Article
Nitrosamines
Tobacco
Biomarkers
Albumins
Hemoglobins
Immune Checkpoint Inhibitors in ROS1-Rearranged Non–Small Cell Lung Cancer: A Report of Two Cases
Jain, A., Fujioka, N. & Patel, M. R., Aug 1 2019, In : Journal of Thoracic Oncology. 14, 8, p. e165-e167Research output: Contribution to journal › Letter
Non-Small Cell Lung Carcinoma
1
Citation
(Scopus)
A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications
Wang, Y., Eans, S. O., Stacy, H. M., Narayanapillai, S. C., Sharma, A., Fujioka, N., Haddad, L., McLaughlin, J., Avery, B. A. & Xing, C., May 1 2018, In : PloS one. 13, 5, e0197940.Research output: Contribution to journal › Article
Open Access
kava
Kava
Pharmacokinetics
isotope dilution technique
Liquid chromatography
1
Citation
(Scopus)
Contribution of Tobacco Use and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone to Three Methyl DNA Adducts in Urine
Wang, Y., Narayanapillai, S., Hu, Q., Fujioka, N. & Xing, C., Sep 17 2018, In : Chemical research in toxicology. 31, 9, p. 836-838 3 p.Research output: Contribution to journal › Article
Tobacco
DNA Adducts
Tobacco Use
Carcinogens
Urine
Identification and analysis of a mercapturic acid conjugate of indole-3-methyl isothiocyanate in the urine of humans who consumed cruciferous vegetables
Upadhyaya, P., Zarth, A. T., Fujioka, N., Fritz, V. A. & Hecht, S. S., Jan 1 2018, In : Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 1072, p. 341-346 6 p.Research output: Contribution to journal › Article
Vegetables
Acetylcysteine
Urine
Brassica
Isothiocyanates